510(k) Report

510(k) · Decided

Decided

Lifestent SDS and XL SDS Biliary Endoprosthesis

K040550510(k) SpecialDecided Mar 16, 200414-day reviewClass II21 CFR 876.5010

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Orbus Medical Technologies · FGE Stents, Drains And Dilators For The Biliary Ducts

Cleared on Mar 16, 2004 as substantially equivalent to K023308 (Orbus Medical Technologies, 2003) and 1 other predicate after a 14-day review. Its family tree reaches back 2 generations to 1994. 1 later device descends from it.

Decided
Mar 16, 2004
Review
14 days
Class
Class II
Product code
FGE
Recalls
None
Predicates
2

Its longest line of descent runs back 2 generations to K941706 (1994). 4 ancestors in all. 1 later device descends from it, 1 citing it directly.

Other ancestors, by generationDescendants, by generation 1 generation back: 1 other ancestor2 generations back: 1 other ancestor 1 generation forward: 1 descendant K033212 · Lifestent SDS Biliary Endoprosthesis · Orbus Medical Technologies · 2003K941706 · Opti-Plast Angioplasty Catheter · Vas-Cath, Inc. · 19940
  1. Root · 2 generations backK941706 Opti-Plast Angioplasty CatheterVas-Cath, Inc. · 1994
  2. 1 generation backK033212 Lifestent SDS Biliary EndoprosthesisOrbus Medical Technologies · 2003
  3. This deviceK040550 Lifestent SDS and XL SDS Biliary EndoprosthesisOrbus Medical Technologies · 2004
  4. Descendant · cites it directly · 0 of its ownK052132 Modification to: Lifestent Valeo Biliary Stent SystemEdwards Lifesciences, LLC · 2005

Most influential descendants

Showing 1 of 1 · See all
  • K052132Modification to: Lifestent Valeo Biliary Stent SystemEdwards Lifesciences, LLC · 2005 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K941706Opti-Plast Angioplasty CatheterVas-Cath, Inc.1994—
−1K033212Lifestent SDS Biliary EndoprosthesisOrbus Medical Technologies2003—
0 (this device)K040550Lifestent SDS and XL SDS Biliary EndoprosthesisOrbus Medical Technologies2004—
+1K052132Modification to: Lifestent Valeo Biliary Stent SystemEdwards Lifesciences, LLC2005—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200110
200310

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200510
FIG. 1 — Lineage of K040550, 1994–2005Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in FGE? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new FGE device

  1. #1 K240464 WallFlex Biliary RX Stent System; Epic Biliary…score 14.5 · 13 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K023308Lifestent SDS Biliary Endoprosthesis, Lifestent XL SDS Biliary Endoprosthesis
Summary page 2
…be considered substantially equivalent to the predicate devices previously cleared per K023308 and line extension to the LifeStent SDS Biliary Endoprosthesis K033212.…
Orbus Medical Technologies2003—
*K033212Lifestent SDS Biliary Endoprosthesis
Summary page 2
…previously cleared per K023308 and line extension to the LifeStent SDS Biliary Endoprosthesis K033212. Page 17 of 20 === Page 3…
Orbus Medical Technologies2003—
†K023121Lifestent Biliary EndoprosthesisOrbus Medical Technologies2003—
†K941706Opti-Plast Angioplasty CatheterVas-Cath, Inc.1994—

Also cleared against K023308: 2 other devices →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K052132Modification to: Lifestent Valeo Biliary Stent SystemEdwards Lifesciences, LLC20050

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 10 years and passes through 2 companies; a new generation was cleared every 9.0 years on median.
  • None of the 4 ancestors has a recall.
  • Of its descendants, K052132 (Edwards Lifesciences, LLC, 2005) has gone furthest, with 0 descendants of its own.
  • 2 other devices also cite its predicate K023308.

How does its category compare?

All FGE devices

FGE Stents, Drains And Dilators For The Biliary Ducts: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · FGE

7in 2025

2007: 42008: 112009: 72010: 92011: 92012: 82013: 52014: 82015: 82016: 42017: 92018: 72019: 22020: 42021: 12022: 62023: 62024: 62025: 72026 (partial year): 8
2007high 11 (2008) · low 1 (2021)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · FGE

257in 2025

2007: 316 days median2008: 214 days median2009: 160 days median2010: 81 days median2011: 114 days median2012: 96 days median2013: 161 days median2014: 156 days median2015: 79 days median2016: 49 days median2017: 59 days median2018: 215 days median2020: 121 days median2022: 101 days median2023: 199 days median2024: 188 days median2025: 257 days median2026 (partial year): 153 days median
2007high 316 (2007) · low 49 (2016)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · FGE

1in 2024

2007: 542008: 932009: 182010: 322011: 22012: 42013: 32017: 12018: 432019: 132020: 12021: 272022: 212023: 192024: 12026 (partial year): 11
2007high 93 (2008) · low 0 (2014)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · FGE

1,923in 2025

2007: 1,0062008: 1,4652009: 1,6552010: 1,4342011: 1,3212012: 1,1832013: 1,0602014: 1,2702015: 1,5432016: 1,4532017: 1,5152018: 1,6812019: 1,8962020: 2,1822021: 2,2972022: 1,7492023: 1,6152024: 1,9482025: 1,923
2007high 2,297 (2021) · low 1,006 (2007)2025

MAUDE reports naming product code FGE, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20074316541,006
200811214931,465
20097160181,655
2010981321,434
2011911421,321
201289641,183
2013516131,060
2014815601,270
201587901,543
201644901,453
201795911,515
20187215431,681
20192—131,896
2020412112,182
20211—272,297
20226101211,749
20236199191,615
2024618811,948
2025725701,923
2026815311—

What is it indicated for?

The Orbus LifeStent XL SDS Biliary Endoprosthesis is indicated for the palliation of malignant neoplasms in the biliary tree.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K040550: Lifestent SDS and XL SDS Biliary Endoprosthesis.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 3, 2026. https://510kreport.com/device/K040550

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026